Safety Needles Market size is estimated to soar to a notable USD 11,972.7 million by 2033 projected CAGR of 7.4%.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Model Lottie Moss is speaking out against the use of diabetes medication for weight loss after she allegedly overdosed on ...

Liraglutide is the first GLP-1 agonist to show benefit in this age group and could provide young patients a much-needed ...

Ozempic (semaglutide) is a once-weekly injectable medication that helps treat type 2 diabetes and reduces the risk of ...

The new discounted single-dose formulation will likely improve access to low doses of the weight loss drug for certain ...

In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other biotech stocks. As we have mentioned in our article, “10 Best Penny Stocks to Buy Under ...

intensifying the company’s race with Novo Nordisk to develop longer-acting insulins. Lilly’s once-weekly insulin, efsitora alfa, reduced the A1C measure of blood sugar comparably to daily ...

Additionally, advancements in needle technology, including ultra-fine needles ... With a focus on technological advancements, Novo Nordisk is developing smart insulin pens integrated with digital ...

Bengaluru: Novo Nordisk said the shortage of lower strengths of its diabetes drug Ozempic has deteriorated, with intermittent shortages for all strengths expected into the final quarter of 2024 ...